… our quality is your success!
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH was founded in 1987 by Prof. Dr. Bernd Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibind®) in the field of fibrinolysis.
Acquisition of the former Immuno diagnostics portfolio from the Baxter AG
From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an own distribution system in Austria, Germany, the UK and Eastern Europe as well through distributors all over the world.
Production and OEM Products
Today, Technoclone is a world leading producer not only of ELISA systems but also of global and special coagulation tests, control and reference plasmas and protein and lipid diagnostics.
With Ceveron® alpha, a fully automated coagulation analyzer, the portfolio has been completed. Ceveron® alpha is not only a coagulation analyzer for clotting, photometric and immunological, latex based coagulation tests but also offers the unique feature of fluorimetric measurement in the routine as it is demanded for Technothrombin® TGA a new thrombin generation test for the determination of thrombophilic tendency, the research of FVIII inhibitor bypass therapy and anticoagulation research.
Another innovation is the Ceveron® MFU 500, a micro particle filtration unit which can identify micro particles thombogenicity in conjunction with the assay Technothrombin® MP.
Technoclone high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogs of international diagnostics companies.
Research and Development
The focus of Technoclone’s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone’s own research division and in close cooperation with universities and international and national research consortia such as the Fighting Aneurysmal Disease (FAD). Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases.
- Technozym® – ELISA (enzyme-linked immunosorbent assay) kits and reagents
- Technothrombin® – thrombin generation assay kits and reagents
- Technochrom® – chromogenic assay kits and reagents
- Technoclot® – clotting assay kits and reagents
- TechnoLEIA® – LEIA (latex enhanced immunoassay) kits and reagents
- Ceveron® – automated coagulation analyzers
- Actibind® – activity and antigen in same sample
Technoclone’s Coagulation Cascade
Download the Technoclone Coagulation Cascade (PDF)